Fga (fibrinogen alpha chain) - Rat Genome Database

Send us a Message

Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Gene: Fga (fibrinogen alpha chain) Rattus norvegicus
Symbol: Fga
Name: fibrinogen alpha chain
RGD ID: 2603
Description: Predicted to enable structural molecule activity. Predicted to contribute to cell adhesion molecule binding activity and signaling receptor binding activity. Involved in several processes, including cellular response to cytokine stimulus; liver regeneration; and response to peptide hormone. Located in blood microparticle. Used to study asthma; brain ischemia; disseminated intravascular coagulation; and thrombocytopenia. Biomarker of acute kidney failure; disseminated intravascular coagulation; pancreatitis; pulmonary embolism; and pulmonary emphysema. Human ortholog(s) of this gene implicated in brain small vessel disease; congenital afibrinogenemia; familial visceral amyloidosis; and thrombophilia. Orthologous to human FGA (fibrinogen alpha chain); PARTICIPATES IN acenocoumarol pharmacodynamics pathway; alteplase pharmacodynamics pathway; aminocaproic acid pharmacodynamics pathway; INTERACTS WITH 1-naphthyl isothiocyanate; 17alpha-ethynylestradiol; 17beta-estradiol.
Type: protein-coding
RefSeq Status: VALIDATED
Previously known as: Ac1873; Fba5e; Fibrinogen A alpha polypeptide; Fibrinogen A alpha polypeptide see also D2Mit19 and D2Wox16; fibrinogen, A alpha polypeptide; fibrinogen, alpha polypeptide; MGC156536
RGD Orthologs
Green Monkey
Naked Mole-Rat
Alliance Genes
More Info more info ...
Latest Assembly: mRatBN7.2 - mRatBN7.2 Assembly
Rat AssemblyChrPosition (strand)SourceGenome Browsers
mRatBN7.22168,374,120 - 168,381,523 (+)NCBImRatBN7.2mRatBN7.2
mRatBN7.2 Ensembl2168,374,120 - 168,381,528 (+)EnsemblmRatBN7.2 Ensembl
UTH_Rnor_SHR_Utx2175,564,269 - 175,571,651 (+)NCBIRnor_SHRUTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.02173,585,204 - 173,592,586 (+)NCBIRnor_SHRSPUTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.02168,186,618 - 168,194,000 (+)NCBIRnor_WKYUTH_Rnor_WKY_Bbb_1.0
Rnor_6.02181,997,562 - 182,013,726 (+)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_6.0 Ensembl2182,006,242 - 182,013,763 (+)EnsemblRnor6.0rn6Rnor6.0
Rnor_5.02201,412,182 - 201,428,346 (+)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.42174,737,640 - 174,753,598 (+)NCBIRGSC3.4RGSC_v3.4rn4RGSC3.4
RGSC_v3.12174,694,725 - 174,703,904 (+)NCBI
Celera2162,392,064 - 162,408,023 (+)NCBICelera
Cytogenetic Map2q34NCBI
JBrowse: View Region in Genome Browser (JBrowse)

Gene-Chemical Interaction Annotations     Click to see Annotation Detail View
(1->4)-beta-D-glucan  (ISO)
1-naphthyl isothiocyanate  (EXP,ISO)
17alpha-ethynylestradiol  (EXP,ISO)
17beta-estradiol  (EXP,ISO)
2,3,7,8-tetrachlorodibenzodioxine  (EXP,ISO)
2-amino-14,16-dimethyloctadecan-3-ol  (ISO)
3,3',4,4',5-pentachlorobiphenyl  (ISO)
3,3',5,5'-tetrabromobisphenol A  (ISO)
3H-1,2-dithiole-3-thione  (EXP)
4,4'-sulfonyldiphenol  (ISO)
6-propyl-2-thiouracil  (EXP)
acetamide  (EXP)
acetylsalicylic acid  (ISO)
aflatoxin B1  (ISO)
ammonium chloride  (EXP)
arachidonyl-2'-chloroethylamide  (ISO)
arsane  (ISO)
arsenic atom  (ISO)
Azaspiracid  (ISO)
azathioprine  (ISO)
benzo[a]pyrene  (ISO)
benzo[a]pyrene diol epoxide I  (ISO)
benzo[b]fluoranthene  (ISO)
bexarotene  (EXP)
bis(2-chloroethyl) sulfide  (EXP)
bisphenol A  (EXP,ISO)
bisphenol F  (ISO)
buspirone  (EXP)
buta-1,3-diene  (ISO)
butanal  (ISO)
cadmium atom  (ISO)
cadmium dichloride  (ISO)
carbon nanotube  (ISO)
carnosic acid  (ISO)
CGP 52608  (ISO)
chloroform  (EXP)
chlorpromazine  (ISO)
choline  (ISO)
cisplatin  (ISO)
clofibric acid  (EXP)
cobalt dichloride  (EXP,ISO)
copper(II) sulfate  (ISO)
cycloheximide  (EXP)
cyclosporin A  (EXP,ISO)
cylindrospermopsin  (ISO)
dabigatran  (ISO)
decabromodiphenyl ether  (EXP)
dibenz[a,h]anthracene  (ISO)
dicrotophos  (ISO)
dienogest  (ISO)
diisopropyl fluorophosphate  (EXP)
diquat  (ISO)
doxorubicin  (ISO)
endosulfan  (EXP)
erythromycin estolate  (EXP)
fenofibrate  (EXP,ISO)
flutamide  (EXP)
folic acid  (ISO)
furan  (EXP)
genistein  (EXP)
gestodene  (ISO)
glafenine  (EXP)
glyphosate  (ISO)
GW 4064  (ISO)
heparin  (ISO)
hydrazine  (ISO)
inulin  (ISO)
L-methionine  (ISO)
lead diacetate  (ISO)
levonorgestrel  (ISO)
lipopolysaccharide  (ISO)
methapyrilene  (EXP)
methidathion  (ISO)
methimazole  (EXP)
methotrexate  (EXP)
methylmercury chloride  (ISO)
morphine  (EXP)
N-nitrosodiethylamine  (EXP)
natamycin  (ISO)
nefazodone  (EXP)
nickel atom  (ISO)
nimesulide  (EXP)
nitrofen  (EXP)
norethisterone  (ISO)
norgestimate  (ISO)
nystatin  (ISO)
O-methyleugenol  (ISO)
ozone  (ISO)
paracetamol  (EXP,ISO)
pentanal  (ISO)
perfluorooctane-1-sulfonic acid  (ISO)
perfluorooctanoic acid  (EXP,ISO)
phenobarbital  (EXP)
phorbol 13-acetate 12-myristate  (EXP)
pirinixic acid  (EXP,ISO)
potassium dichromate  (ISO)
pregnenolone 16alpha-carbonitrile  (EXP,ISO)
progesterone  (ISO)
propanal  (ISO)
quercetin  (ISO)
quinidine  (EXP)
rotenone  (ISO)
silicon dioxide  (ISO)
silver atom  (ISO)
silver(0)  (ISO)
sodium arsenate  (ISO)
sodium arsenite  (ISO)
sodium dichromate  (EXP)
sulfasalazine  (ISO)
tacrolimus hydrate  (EXP)
tetrachloromethane  (EXP)
tetracycline  (EXP)
theophylline  (EXP)
tolcapone  (EXP)
tremolite asbestos  (ISO)
tributylstannane  (ISO)
Triptolide  (EXP)
trovafloxacin  (ISO)
urethane  (ISO)
valproic acid  (EXP,ISO)
vancomycin  (ISO)
zinc atom  (ISO)
zinc(0)  (ISO)

Gene Ontology Annotations     Click to see Annotation Detail View

Biological Process
acute-phase response  (IEP)
adaptive immune response  (IEA)
blood coagulation  (ISO)
blood coagulation, common pathway  (IBA,IEA,ISO)
blood coagulation, fibrin clot formation  (ISO)
cell-matrix adhesion  (ISO)
cellular response to granulocyte colony-stimulating factor  (IEP)
cellular response to interleukin-6  (IEP)
cellular response to organic cyclic compound  (IEP)
envenomation resulting in modulation of blood coagulation in another organism  (IEP)
fibrinolysis  (IBA,IEA,ISO)
induction of bacterial agglutination  (ISO)
innate immune response  (IEA)
liver regeneration  (IEP)
negative regulation of endothelial cell apoptotic process  (IBA,IEA,ISO)
negative regulation of extrinsic apoptotic signaling pathway via death domain receptors  (IBA,IEA,ISO)
plasminogen activation  (ISO)
platelet aggregation  (IBA,IEA,ISO)
positive regulation of ERK1 and ERK2 cascade  (IBA,IEA,ISO)
positive regulation of exocytosis  (ISO)
positive regulation of heterotypic cell-cell adhesion  (IBA,IEA,ISO)
positive regulation of peptide hormone secretion  (IBA,IEA,ISO)
positive regulation of protein secretion  (ISO)
positive regulation of smooth muscle cell migration  (IDA)
positive regulation of vasoconstriction  (ISO)
protein polymerization  (IBA,IEA,ISO)
protein-containing complex assembly  (ISO)
response to calcium ion  (ISO)
response to cycloheximide  (IEP)
response to estradiol  (IEP)
response to genistein  (IEP)
response to growth hormone  (IEP)
response to insulin  (IEP)
response to thyroid hormone  (IEP)
response to toxic substance  (IEP)
response to X-ray  (IEP)

Cellular Component

Molecular Function


References - curated
# Reference Title Reference Citation
1. Therapy with interleukin-22 alleviates hepatic injury and hemostasis dysregulation in rat model of acute liver failure. Ashour TH Adv Hematol. 2014;2014:705290. doi: 10.1155/2014/705290. Epub 2014 Apr 1.
2. Serum peptidome based biomarkers searching for monitoring minimal residual disease in adult acute lymphocytic leukemia. Bai J, etal., Proteome Sci. 2014 Sep 16;12(1):49. doi: 10.1186/s12953-014-0049-y. eCollection 2014.
3. Preliminary identification of differentially expressed tear proteins in keratoconus. Balasubramanian SA, etal., Mol Vis. 2013 Oct 30;19:2124-34. eCollection 2013.
4. The effects of melatonin on burn-induced inflammatory responses and coagulation disorders in rats. Bekyarova G, etal., Methods Find Exp Clin Pharmacol. 2010 Jun;32(5):299-303.
5. Hereditary renal amyloidosis associated with a mutant fibrinogen alpha-chain. Benson MD, etal., Nat Genet. 1993 Mar;3(3):252-5.
6. alpha-fibrinogen Thr312Ala polymorphism and venous thromboembolism. Carter AM, etal., Blood. 2000 Aug 1;96(3):1177-9.
7. Quantitative organellar proteomics analysis of rough endoplasmic reticulum from normal and acute pancreatitis rat pancreas. Chen X, etal., J Proteome Res. 2010 Feb 5;9(2):885-96.
8. Hypoglycemic dipeptide cyclo (His-Pro) significantly altered plasma proteome in streptozocin-induced diabetic rats and genetically-diabetic (ob/ob) mice. Choi SA, etal., Mol Biol Rep. 2013 Feb;40(2):1753-65. doi: 10.1007/s11033-012-2229-0. Epub 2012 Oct 20.
9. Molecular cloning of cDNA for the alpha, beta, and gamma chains of rat fibrinogen. A family of coordinately regulated genes. Crabtree GR and Kant JA, J Biol Chem. 1981 Sep 25;256(18):9718-23.
10. Coordinate accumulation of the mRNAs for the alpha, beta, and gamma chains of rat fibrinogen following defibrination. Crabtree GR and Kant JA, J Biol Chem. 1982 Jul 10;257(13):7277-9.
11. Puerarin attenuates ovalbumin-induced lung inflammation and hemostatic unbalance in rat asthma model. Dong F, etal., Evid Based Complement Alternat Med. 2014;2014:726740. doi: 10.1155/2014/726740. Epub 2014 Jan 2.
12. Induction of fibrinogen and a subset of acute phase response genes involves a novel monokine which is mimicked by phorbol esters. Evans E, etal., J Biol Chem. 1987 Aug 5;262(22):10850-4.
13. The effects of sleep hypoxia on coagulant factors and hepatic inflammation in emphysematous rats. Feng J, etal., PLoS One. 2010 Oct 6;5(10):e13201. doi: 10.1371/journal.pone.0013201.
14. Fibrinogen alpha genes: conservation of bipartite transcripts and carboxy-terminal-extended alpha subunits in vertebrates. Fu Y, etal., Genomics 1995 Nov 1;30(1):71-6.
15. Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium. Gaudet P, etal., Brief Bioinform. 2011 Sep;12(5):449-62. doi: 10.1093/bib/bbr042. Epub 2011 Aug 27.
16. Effects of hypophysectomy of liver donor on net synthesis of specific plasma proteins by the isolated perfused rat liver. Modulation of synthesis of albumin, fibrinogen, alpha 1-acid glycoprotein, alpha 2-(acute phase)-globulin, and haptoglobin by insulin, cortisol, triiodothyronine, and growth hormone. Griffin EE and Miller LL, J Biol Chem. 1974 Aug 25;249(16):5062-9.
17. Enoxaparin attenuates endothelial damage with less bleeding compared with unfractionated heparin in endotoxemic rats. Iba T and Takayama T, Shock. 2009 Nov;32(5):530-4. doi: 10.1097/SHK.0b013e3181a2e279.
18. [Protective effects and anticoagulation effect of polysaccharides from the sea cucumber on acute incomplete cerebral ischemia in rats]. Jiang X, etal., Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2012 Mar;28(2):170-2.
19. Identification of potential biomarkers by serum proteomics analysis in rats with sepsis. Jiao J, etal., Shock. 2014 Jul;42(1):75-81. doi: 10.1097/SHK.0000000000000173.
20. Down-regulated expression of AQP5 on lung in rat DIC model induced by LPS and its effect on the development of pulmonary edema. Jin Y, etal., Pulm Pharmacol Ther. 2013 Dec;26(6):661-5. doi: 10.1016/j.pupt.2013.03.013. Epub 2013 Mar 26.
21. Effect of whole x-irradiation of rats on net synthesis of albumin, fibrinogen, alpha-1-acid glycoprotein, and alpha-2-globulin (acute phase globulin) by the isolated, perfused rat liver. John DW and Miller LL, J Biol Chem. 1968 Jan 25;243(2):268-73.
22. Genistein alters coagulation gene expression in ovariectomised rats treated with phytoestrogens. Kelly LA, etal., Thromb Haemost. 2010 Sep 13;104(6).
23. Protein tyrosine phosphatase 2 (SHP-2) moderates signaling by gp130 but is not required for the induction of acute-phase plasma protein genes in hepatic cells. Kim H, etal., Mol Cell Biol. 1998 Mar;18(3):1525-33.
24. Haemostatic abnormalities persist despite glycaemic improvement by insulin therapy in lean type 2 diabetic patients. Knobl P, etal., Thromb Haemost. 1994 Jun;71(6):692-7.
25. Fibrinogen beta-derived Bbeta(15-42) peptide protects against kidney ischemia/reperfusion injury. Krishnamoorthy A, etal., Blood. 2011 Aug 18;118(7):1934-42. Epub 2011 Jun 17.
26. The fibrin-derived peptide bbeta15-42 attenuates liver damage in a rat model of liver ischemia/reperfusion injury. Liu A, etal., Shock. 2013 Apr;39(4):397-403. doi: 10.1097/SHK.0b013e31828c2b75.
27. [Experimental anticoagulant therapy of acute lung injury induced by paraquat]. Liu F, etal., Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2012 Mar;30(3):190-3.
28. Basic mechanisms and regulation of fibrinolysis. Longstaff C and Kolev K, J Thromb Haemost. 2015 Jun;13 Suppl 1:S98-105. doi: 10.1111/jth.12935.
29. Identification of genetic risk variants for deep vein thrombosis by multiplexed next-generation sequencing of 186 hemostatic/pro-inflammatory genes. Lotta LA, etal., BMC Med Genomics. 2012 Feb 21;5(1):7.
30. Fibrinogen alpha-chain-derived peptide is upregulated in hippocampus of rats exposed to acute morphine injection and spontaneous alternation testing. Maki AE, etal., Pharmacol Res Perspect. 2014 Jun 1;2(3):e00037.
31. Rat ISS GO annotations from MGI mouse gene data--August 2006 MGD data from the GO Consortium
32. Fibrinogen and fibrin structure and functions. Mosesson MW J Thromb Haemost. 2005 Aug;3(8):1894-904.
33. A label-free nano-liquid chromatography-mass spectrometry approach for quantitative serum peptidomics in Crohn's disease patients. Nanni P, etal., J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Oct 1;877(27):3127-36. Epub 2009 Aug 7.
34. Electronic Transfer of LocusLink and RefSeq Data NCBI rat LocusLink and RefSeq merged data July 26, 2002
35. The 11 kb FGA deletion responsible for congenital afibrinogenaemia is mediated by a short direct repeat in the fibrinogen gene cluster. Neerman-Arbez M, etal., Eur J Hum Genet. 1999 Dec;7(8):897-902.
36. Antiplatelet and antithrombotic effects of platelet glycoprotein IIb/IIIa (GPIIb/IIIa) inhibition by arginine-glycine-aspartic acid-serine (RGDS) and arginine-glycine-aspartic acid (RGD) (O-me)Y (SC-46749). Nicholson NS, etal., J Pharmacol Exp Ther. 1991 Mar;256(3):876-82.
37. OMIM Disease Annotation Pipeline OMIM Disease Annotation Pipeline
38. Online Mendelian Inheritance in Man, OMIM (TM). Online Mendelian Inheritance in Man, OMIM (TM).
39. KEGG Annotation Import Pipeline Pipeline to import KEGG annotations from KEGG into RGD
40. PID Annotation Import Pipeline Pipeline to import Pathway Interaction Database annotations from NCI into RGD
41. SMPDB Annotation Import Pipeline Pipeline to import SMPDB annotations from SMPDB into RGD
42. Distribution of mRNAS of fibrinogen polypeptides and albumin in free and membrane-bound polyribosomes and induction of alpha-fetoprotein mRNA synthesis during liver regeneration after partial hepatectomy. Princen HM, etal., Biochim Biophys Acta. 1982 Nov 30;699(2):121-30.
43. Cycloheximide as a probe of fibrinogen synthesis. Procyk R, etal., Biochem J. 1979 Feb 15;178(2):501-4.
44. GOA pipeline RGD automated data pipeline
45. ClinVar Automated Import and Annotation Pipeline RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations
46. Data Import for Chemical-Gene Interactions RGD automated import pipeline for gene-chemical interactions
47. Comprehensive gene review and curation RGD comprehensive gene curation
48. Molecular cloning of mRNA sequences transiently induced during rat liver regeneration. Sobczak J, etal., Exp Cell Res 1987 Mar;169(1):47-56.
49. Prediction of nephrotoxicant action and identification of candidate toxicity-related biomarkers. Thukral SK, etal., Toxicol Pathol. 2005;33(3):343-55.
50. Haplotypes of the fibrinogen gene and cerebral small vessel disease: the Rotterdam scan study. van Oijen M, etal., J Neurol Neurosurg Psychiatry. 2008 Jul;79(7):799-803. Epub 2007 Oct 19.
51. Congenital afibrinogenaemia in a newborn infant due to a novel mutation in the fibrinogen aalpha gene. Vlietman JJ, etal., Br J Haematol. 2002 Oct;119(1):282-3.
52. Pre-treatment with bone marrow-derived mesenchymal stem cells inhibits systemic intravascular coagulation and attenuates organ dysfunction in lipopolysaccharide-induced disseminated intravascular coagulation rat model. Wang B, etal., Chin Med J (Engl). 2012 May;125(10):1753-9.
53. Intravenous release of NO from lipidic microbubbles accelerates deep vein thrombosis resolution in a rat model. Wang C, etal., Thromb Res. 2013 Jan;131(1):e31-8. doi: 10.1016/j.thromres.2012.11.002. Epub 2012 Nov 28.
54. Defibrinogenating effect of batroxobin (Defibrase) in rats and inhibition of migration of human vascular smooth muscle cells by the plasma of batroxobin-treated rats in vitro. Wang DS, etal., Atherosclerosis. 2001 May;156(1):73-80.
55. Identification of novel biomarkers in seasonal allergic rhinitis by combining proteomic, multivariate and pathway analysis. Wang H, etal., PLoS One. 2011;6(8):e23563. Epub 2011 Aug 24.
56. Proteomics of microparticles after experimental pulmonary embolism. Watts JA, etal., Thromb Res. 2011 Oct 17.
57. A novel nonsense mutation in the FGA gene in a Chinese family with congenital afibrinogenaemia. Wu S, etal., Blood Coagul Fibrinolysis. 2005 Apr;16(3):221-6.
Additional References at PubMed
PMID:6281794   PMID:6777381   PMID:8100742   PMID:8910396   PMID:9182580   PMID:10891444   PMID:10903502   PMID:10930441   PMID:12477932   PMID:12706644   PMID:15739255   PMID:15914557  
PMID:16452087   PMID:16846481   PMID:18676163   PMID:19056867   PMID:19193866   PMID:22516433   PMID:22819533   PMID:23376485   PMID:23382103   PMID:23533145   PMID:24367264   PMID:24769233  
PMID:27469290   PMID:29768263  


Comparative Map Data
(Rattus norvegicus - Norway rat)
Rat AssemblyChrPosition (strand)SourceGenome Browsers
mRatBN7.22168,374,120 - 168,381,523 (+)NCBImRatBN7.2mRatBN7.2
mRatBN7.2 Ensembl2168,374,120 - 168,381,528 (+)EnsemblmRatBN7.2 Ensembl
UTH_Rnor_SHR_Utx2175,564,269 - 175,571,651 (+)NCBIRnor_SHRUTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.02173,585,204 - 173,592,586 (+)NCBIRnor_SHRSPUTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.02168,186,618 - 168,194,000 (+)NCBIRnor_WKYUTH_Rnor_WKY_Bbb_1.0
Rnor_6.02181,997,562 - 182,013,726 (+)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_6.0 Ensembl2182,006,242 - 182,013,763 (+)EnsemblRnor6.0rn6Rnor6.0
Rnor_5.02201,412,182 - 201,428,346 (+)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.42174,737,640 - 174,753,598 (+)NCBIRGSC3.4RGSC_v3.4rn4RGSC3.4
RGSC_v3.12174,694,725 - 174,703,904 (+)NCBI
Celera2162,392,064 - 162,408,023 (+)NCBICelera
Cytogenetic Map2q34NCBI
(Homo sapiens - human)
Human AssemblyChrPosition (strand)SourceGenome Browsers
GRCh384154,583,126 - 154,590,742 (-)NCBIGRCh38GRCh38hg38GRCh38
GRCh38.p14 Ensembl4154,583,126 - 154,590,742 (-)EnsemblGRCh38hg38GRCh38
GRCh374155,504,278 - 155,511,894 (-)NCBIGRCh37GRCh37hg19GRCh37
Build 364155,723,730 - 155,731,347 (-)NCBINCBI36Build 36hg18NCBI36
Build 344155,864,033 - 155,869,470NCBI
Celera4152,835,246 - 152,842,862 (-)NCBICelera
Cytogenetic Map4q31.3NCBI
HuRef4151,244,861 - 151,252,473 (-)NCBIHuRef
CHM1_14155,482,201 - 155,489,817 (-)NCBICHM1_1
T2T-CHM13v2.04157,914,895 - 157,922,551 (-)NCBIT2T-CHM13v2.0
(Mus musculus - house mouse)
Mouse AssemblyChrPosition (strand)SourceGenome Browsers
GRCm39382,933,460 - 82,940,934 (+)NCBIGRCm39GRCm39mm39
GRCm39 Ensembl382,933,383 - 82,940,934 (+)EnsemblGRCm39 Ensembl
GRCm38383,026,153 - 83,033,627 (+)NCBIGRCm38GRCm38mm10GRCm38
GRCm38.p6 Ensembl383,026,076 - 83,033,627 (+)EnsemblGRCm38mm10GRCm38
MGSCv37382,830,075 - 82,837,549 (+)NCBIGRCm37MGSCv37mm9NCBIm37
MGSCv36383,112,081 - 83,118,197 (+)NCBIMGSCv36mm8
Celera383,030,275 - 83,037,743 (+)NCBICelera
Cytogenetic Map3E3NCBI
cM Map336.96NCBI
(Chinchilla lanigera - long-tailed chinchilla)
Chinchilla AssemblyChrPosition (strand)SourceGenome Browsers
ChiLan1.0 EnsemblNW_0049554718,806,650 - 8,816,791 (+)EnsemblChiLan1.0
ChiLan1.0NW_0049554718,806,964 - 8,814,671 (+)NCBIChiLan1.0ChiLan1.0
(Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo AssemblyChrPosition (strand)SourceGenome Browsers
NHGRI_mPanPan14152,851,017 - 152,858,630 (-)NCBINHGRI_mPanPan1
Mhudiblu_PPA_v04146,949,680 - 146,957,291 (-)NCBIMhudiblu_PPA_v0Mhudiblu_PPA_v0panPan3
PanPan1.14158,767,782 - 158,775,414 (-)NCBIpanpan1.1PanPan1.1panPan2
(Canis lupus familiaris - dog)
Dog AssemblyChrPosition (strand)SourceGenome Browsers
CanFam3.11552,238,305 - 52,247,017 (-)NCBICanFam3.1CanFam3.1canFam3CanFam3.1
CanFam3.1 Ensembl1552,236,198 - 52,246,975 (-)EnsemblCanFam3.1canFam3CanFam3.1
Dog10K_Boxer_Tasha1552,584,628 - 52,591,483 (-)NCBIDog10K_Boxer_Tasha
ROS_Cfam_1.01552,924,743 - 52,933,990 (-)NCBIROS_Cfam_1.0
UMICH_Zoey_3.11552,179,682 - 52,188,900 (-)NCBIUMICH_Zoey_3.1
UNSW_CanFamBas_1.01552,283,995 - 52,293,478 (-)NCBIUNSW_CanFamBas_1.0
UU_Cfam_GSD_1.01552,601,176 - 52,608,068 (-)NCBIUU_Cfam_GSD_1.0
(Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel AssemblyChrPosition (strand)SourceGenome Browsers
HiC_Itri_2NW_02440530138,217,093 - 38,224,715 (+)NCBIHiC_Itri_2
SpeTri2.0NW_0049365761,322,406 - 1,329,743 (-)NCBISpeTri2.0SpeTri2.0SpeTri2.0
(Sus scrofa - pig)
Pig AssemblyChrPosition (strand)SourceGenome Browsers
Sscrofa11.1 Ensembl874,574,882 - 74,584,202 (+)EnsemblSscrofa11.1susScr11Sscrofa11.1
Sscrofa11.1874,574,870 - 74,584,202 (+)NCBISscrofa11.1Sscrofa11.1susScr11Sscrofa11.1
Sscrofa10.2878,935,842 - 78,938,718 (+)NCBISscrofa10.2Sscrofa10.2susScr3
(Chlorocebus sabaeus - green monkey)
Green Monkey AssemblyChrPosition (strand)SourceGenome Browsers
ChlSab1.17101,127,554 - 101,134,881 (-)NCBIChlSab1.1ChlSab1.1chlSab2
ChlSab1.1 Ensembl7101,125,791 - 101,134,405 (-)EnsemblChlSab1.1ChlSab1.1 EnsemblchlSab2
Vero_WHO_p1.0NW_02366603780,782,883 - 80,789,839 (-)NCBIVero_WHO_p1.0Vero_WHO_p1.0
(Heterocephalus glaber - naked mole-rat)
Naked Mole-Rat AssemblyChrPosition (strand)SourceGenome Browsers
HetGla 1.0NW_0046248585,848,817 - 5,856,448 (+)NCBIHetGla_female_1.0HetGla 1.0hetGla2


Variants in Fga
63 total Variants
miRNA Target Status

Predicted Target Of
Summary Value
Count of predictions:485
Count of miRNA genes:260
Interacting mature miRNAs:320
Transcripts:ENSRNOT00000012192, ENSRNOT00000064091, ENSRNOT00000064150
Prediction methods:Microtar, Miranda, Rnahybrid, Targetscan
Result types:miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/).
For more information about miRGate, see PMID:25858286 or access the full paper here.

QTLs in Region (mRatBN7.2)
The following QTLs overlap with this region.    Full Report CSV TAB Printer Gviewer
RGD IDSymbolNameLODP ValueTraitSub TraitChrStartStopSpecies
1358913Cm41Cardiac mass QTL 412.73heart mass (VT:0007028)heart weight to body weight ratio (CMO:0000074)225413423203928301Rat
1358917Cm42Cardiac mass QTL 422.82heart mass (VT:0007028)heart weight to body weight ratio (CMO:0000074)225413423203928301Rat
2293843Kiddil6Kidney dilation QTL 63.1kidney pelvis morphology trait (VT:0004194)hydronephrosis severity score (CMO:0001208)242804607182042367Rat
1298074Bp164Blood pressure QTL 1640.003arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)242804607202447032Rat
1298085Bp165Blood pressure QTL 1650.0006arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)242804607202447032Rat
61467Bp14Blood pressure QTL 142.2arterial blood pressure trait (VT:2000000)diastolic blood pressure (CMO:0000005)243154682202446871Rat
61467Bp14Blood pressure QTL 142.2arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)243154682202446871Rat
1354601Slep1Serum leptin concentration QTL 15.39blood leptin amount (VT:0005667)serum leptin level (CMO:0000780)243171017184114403Rat
631266Bp132Blood pressure QTL 1320.0005arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)246123260202447032Rat
1331760Bp206Blood pressure QTL 2063.62454arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)256043031202447032Rat
1298080Bp163Blood pressure QTL 1630.02arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)266118275202447032Rat
1354648Bp239Blood pressure QTL 2390.001arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)266118463226797303Rat
1354605Rf48Renal function QTL 482.9blood creatinine amount (VT:0005328)plasma creatinine level (CMO:0000537)274786664206665859Rat
61374Edpm2Estrogen-dependent pituitary mass QTL 24.420.86pituitary gland mass (VT:0010496)pituitary gland wet weight (CMO:0000853)276539322202447032Rat
1581569Uae32Urinary albumin excretion QTL 320.0001urine protein amount (VT:0005160)urine albumin excretion rate (CMO:0000757)278665619219826953Rat
724534Uae6Urinary albumin excretion QTL 610urine albumin amount (VT:0002871)urine albumin level (CMO:0000130)278665619249053267Rat
8662832Vetf7Vascular elastic tissue fragility QTL 73.5aorta elastin amount (VT:0003905)aorta wall extracellular elastin dry weight to aorta wall dry weight ratio (CMO:0002002)281689826221035911Rat
1354622Kidm16Kidney mass QTL 163kidney mass (VT:0002707)left kidney wet weight (CMO:0000083)281754530222436696Rat
1354649Kidm17Kidney mass QTL 172.9kidney mass (VT:0002707)calculated kidney weight (CMO:0000160)281754530227146641Rat
631507Bp105Blood pressure QTL 1050.001arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)2112456140212696837Rat
634308Sach6Saccharin preference QTL 64.9taste sensitivity trait (VT:0001986)saccharin intake volume to total fluid intake volume ratio (CMO:0001601)2112456140212696837Rat
1359030Bp277Blood pressure QTL 277arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)2114837527185876470Rat
1359030Bp277Blood pressure QTL 277arterial blood pressure trait (VT:2000000)diastolic blood pressure (CMO:0000005)2114837527185876470Rat
1578648Bss11Bone structure and strength QTL 114.7femur morphology trait (VT:0000559)femoral neck cortical cross-sectional area (CMO:0001702)2114837527211674221Rat
1554319Bmd2Bone mineral density QTL 213.40.0001lumbar vertebra area (VT:0010570)lumbar vertebra cross-sectional area (CMO:0001689)2114837675212549332Rat
6907363Bp357Blood pressure QTL 3574.10.002arterial blood pressure trait (VT:2000000)diastolic blood pressure (CMO:0000005)2129540907174540907Rat
1300165Rf9Renal function QTL 93.28kidney glomerulus integrity trait (VT:0010546)index of glomerular damage (CMO:0001135)2133914684202447032Rat
70175BpQTLCluster3Blood pressure QTL cluster 34.128arterial blood pressure trait (VT:2000000)diastolic blood pressure (CMO:0000005)2135552573202446871Rat
70175BpQTLCluster3Blood pressure QTL cluster 34.128arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)2135552573202446871Rat
70175BpQTLCluster3Blood pressure QTL cluster 34.128arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)2135552573202446871Rat
70175BpQTLCluster3Blood pressure QTL cluster 34.128arterial blood pressure trait (VT:2000000)pulse pressure (CMO:0000292)2135552573202446871Rat
70175BpQTLCluster3Blood pressure QTL cluster 34.128arterial blood pressure trait (VT:2000000)absolute change in systolic blood pressure (CMO:0000607)2135552573202446871Rat
1298076Bp166Blood pressure QTL 1660.0009arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)2136445150202447032Rat
1581502Esta3Estrogen-induced thymic atrophy QTL 3thymus mass (VT:0004954)thymus wet weight (CMO:0000855)2136916935189599348Rat
1359022Ppulsi1Prepulse inhibition QTL 13.63prepulse inhibition trait (VT:0003088)acoustic startle response measurement (CMO:0001519)2136916935213594495Rat
1331794Bp202Blood pressure QTL 2023.66819arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)2141194931223265385Rat
1331805Cm29Cardiac mass QTL 293.50746heart mass (VT:0007028)heart wet weight (CMO:0000069)2141194931223265385Rat
71113Cari2Carrageenan-induced inflammation QTL 22.70.009hypodermis integrity trait (VT:0010550)inflammatory exudate volume (CMO:0001429)2141596551202447032Rat
724568Uae13Urinary albumin excretion QTL 134.4urine albumin amount (VT:0002871)urine albumin excretion rate (CMO:0000757)2143157029210020885Rat
10043136Iddm54Insulin dependent diabetes mellitus QTL 543.40.0001blood glucose amount (VT:0000188)blood glucose level (CMO:0000046)2143657411190602963Rat
10043136Iddm54Insulin dependent diabetes mellitus QTL 543.40.0001blood glucose amount (VT:0000188)age at onset/diagnosis of type 1 diabetes mellitus (CMO:0001140)2143657411190602963Rat
6903312Bw112Body weight QTL 1123.20.0013body mass (VT:0001259)body weight (CMO:0000012)2143657569184114274Rat
61401Niddm2Non-insulin dependent diabetes mellitus QTL 24.54blood glucose amount (VT:0000188)blood glucose level (CMO:0000046)2144599348189599348Rat
1598833Bp295Blood pressure QTL 2953.5arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)2147798556192798556Rat
1641925Alcrsp2Alcohol response QTL 2response to alcohol trait (VT:0010489)duration of loss of righting reflex (CMO:0002289)2149559561221167075Rat
1641891Alcrsp17Alcohol response QTL 17response to alcohol trait (VT:0010489)duration of loss of righting reflex (CMO:0002289)2149559561249053267Rat
1598805Memor8Memory QTL 83exploratory behavior trait (VT:0010471)average horizontal distance between subject and target during voluntary locomotion in an experimental apparatus (CMO:0002674)2150341585189039377Rat
631501Bp101Blood pressure QTL 1012.4arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)2150341684202446871Rat
2301966Bp322Blood pressure QTL 3223.58arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)2150540301202447032Rat
1354609Niddm62Non-insulin dependent diabetes mellitus QTL 624.720.000006insulin secretion trait (VT:0003564)plasma insulin level (CMO:0000342)2150540301202447032Rat
12879845Cm89Cardiac mass QTL 890.008heart left ventricle mass (VT:0007031)heart left ventricle weight to body weight ratio (CMO:0000530)2152413072175950118Rat
12879846Cm90Cardiac mass QTL 900.011heart right ventricle mass (VT:0007033)heart right ventricle weight to body weight ratio (CMO:0000914)2152413072175950118Rat
12879847Am4Aortic mass QTL 40.001aorta mass (VT:0002845)aorta weight to aorta length to body weight ratio (CMO:0002722)2152413072175950118Rat
11565180Kidm56Kidney mass QTL 560.003kidney mass (VT:0002707)both kidneys wet weight to body weight ratio (CMO:0000340)2152413072175950118Rat
11565181Bw176Body weight QTL 1760.002body mass (VT:0001259)body weight (CMO:0000012)2152413072175950118Rat
2301415Cm67Cardiac mass QTL 670.003heart mass (VT:0007028)heart wet weight to body weight ratio (CMO:0002408)2152413072175950118Rat
12879836Kidm61Kidney mass QTL 610.001kidney mass (VT:0002707)both kidneys wet weight to body weight ratio (CMO:0000340)2152413072185122374Rat
12879837Am2Aortic mass QTL 20.001aorta mass (VT:0002845)aorta weight to aorta length to body weight ratio (CMO:0002722)2152413072185122374Rat
12879838Cm86Cardiac mass QTL 860.002heart left ventricle mass (VT:0007031)heart left ventricle weight to body weight ratio (CMO:0000530)2152413072185122374Rat
12879839Cm85Cardiac mass QTL 850.001heart mass (VT:0007028)heart wet weight to body weight ratio (CMO:0002408)2152413072185122374Rat
12879840Bw179Body weight QTL 1790.005body mass (VT:0001259)body weight (CMO:0000012)2152413072185122374Rat
1359032Hrtrt18Heart rate QTL 18heart pumping trait (VT:2000009)heart rate (CMO:0000002)2157142078192625452Rat
1358900Bw48Body weight QTL 484.88body mass (VT:0001259)body weight (CMO:0000012)2157142078211086598Rat
8662843Vetf9Vascular elastic tissue fragility QTL 92.05thoracic aorta molecular composition trait (VT:0010568)aorta wall extracellular elastin dry weight to aorta wall extracellular collagen weight ratio (CMO:0002003)2157142078226277316Rat
1302793Bw16Body weight QTL 1650.0001body mass (VT:0001259)body weight (CMO:0000012)2157142209202446871Rat
7488925Bp364Blood pressure QTL 3640.001arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)2160564068205564068Rat
1358356Srcrt1Stress Responsive Cort QTL13.66blood corticosterone amount (VT:0005345)plasma corticosterone level (CMO:0001173)2161699179222436696Rat
7488927Bp365Blood pressure QTL 3650.008arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)2162765032207765032Rat
2306901Bp337Blood pressure QTL 3370.01arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)2164073756227146641Rat
1598838Bp290Blood pressure QTL 2901.9arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)2166539266211539266Rat
1549833Bp257Blood pressure QTL 2570.003arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)2168354880185122374Rat
1331734Bp204Blood pressure QTL 2043.61192arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)2168358098223265385Rat

Markers in Region
Rat AssemblyChrPosition (strand)SourceJBrowse
mRatBN7.22168,377,888 - 168,378,009 (+)MAPPERmRatBN7.2
Rnor_6.02182,010,087 - 182,010,207NCBIRnor6.0
Rnor_5.02201,424,707 - 201,424,827UniSTSRnor5.0
RGSC_v3.42174,750,164 - 174,750,285RGDRGSC3.4
RGSC_v3.42174,750,165 - 174,750,285UniSTSRGSC3.4
RGSC_v3.12174,700,270 - 174,700,391RGD
Celera2162,404,589 - 162,404,709UniSTS
Cytogenetic Map2q34UniSTS
Rat AssemblyChrPosition (strand)SourceJBrowse
RGSC_v3.42174,750,165 - 174,750,280UniSTSRGSC3.4
Celera2162,404,589 - 162,404,704UniSTS
Cytogenetic Map2 RGD
Rat AssemblyChrPosition (strand)SourceJBrowse
mRatBN7.22168,377,796 - 168,378,138 (+)MAPPERmRatBN7.2
Rnor_6.02182,009,995 - 182,010,336NCBIRnor6.0
Rnor_5.02201,424,615 - 201,424,956UniSTSRnor5.0
RGSC_v3.42174,750,072 - 174,750,414RGDRGSC3.4
RGSC_v3.42174,750,073 - 174,750,414UniSTSRGSC3.4
RGSC_v3.12174,700,178 - 174,700,520RGD
Celera2162,404,497 - 162,404,838UniSTS
FHH x ACI Map275.4999UniSTS
FHH x ACI Map275.4999RGD
Cytogenetic Map2q34UniSTS
Rat AssemblyChrPosition (strand)SourceJBrowse
mRatBN7.22168,380,012 - 168,380,169 (+)MAPPERmRatBN7.2
Rnor_6.02182,012,211 - 182,012,367NCBIRnor6.0
Rnor_5.02201,426,831 - 201,426,987UniSTSRnor5.0
RGSC_v3.42174,752,289 - 174,752,445UniSTSRGSC3.4
Celera2162,406,713 - 162,406,869UniSTS
Cytogenetic Map2q34UniSTS
Rat AssemblyChrPosition (strand)SourceJBrowse
mRatBN7.22168,381,230 - 168,381,413 (+)MAPPERmRatBN7.2
Rnor_6.02182,013,429 - 182,013,611NCBIRnor6.0
Rnor_5.02201,428,049 - 201,428,231UniSTSRnor5.0
RGSC_v3.42174,753,507 - 174,753,689UniSTSRGSC3.4
Celera2162,407,931 - 162,408,113UniSTS
RH 3.4 Map21098.7UniSTS
Cytogenetic Map2q34UniSTS
Rat AssemblyChrPosition (strand)SourceJBrowse
mRatBN7.22168,379,056 - 168,379,466 (+)MAPPERmRatBN7.2
Rnor_6.02182,011,255 - 182,011,664NCBIRnor6.0
Rnor_5.02201,425,875 - 201,426,284UniSTSRnor5.0
RGSC_v3.42174,751,333 - 174,751,742UniSTSRGSC3.4
Celera2162,405,757 - 162,406,166UniSTS
Cytogenetic Map2q34UniSTS
Rat AssemblyChrPosition (strand)SourceJBrowse
mRatBN7.22168,377,888 - 168,378,004 (+)MAPPERmRatBN7.2
Rnor_6.02182,010,087 - 182,010,202NCBIRnor6.0
Rnor_5.02201,424,707 - 201,424,822UniSTSRnor5.0
RGSC_v3.42174,750,165 - 174,750,280UniSTSRGSC3.4
Celera2162,404,589 - 162,404,704UniSTS
Cytogenetic Map2q34UniSTS


RNA-SEQ Expression
High: > 1000 TPM value   Medium: Between 11 and 1000 TPM
Low: Between 0.5 and 10 TPM   Below Cutoff: < 0.5 TPM

alimentary part of gastrointestinal system circulatory system endocrine system exocrine system hemolymphoid system hepatobiliary system integumental system musculoskeletal system nervous system renal system reproductive system respiratory system appendage
High 29 29 29
Medium 14 12 12 1 1 15 2 1 1
Low 6 14 16 6 6 27 16 23 7 6
Below cutoff 2 10 2 1 2 27 2 12 1 1


RefSeq Acc Id: ENSRNOT00000064091   ⟹   ENSRNOP00000060007
Rat AssemblyChrPosition (strand)Source
mRatBN7.2 Ensembl2168,374,120 - 168,381,528 (+)Ensembl
Rnor_6.0 Ensembl2182,006,242 - 182,013,763 (+)Ensembl
RefSeq Acc Id: ENSRNOT00000094522   ⟹   ENSRNOP00000088145
Rat AssemblyChrPosition (strand)Source
mRatBN7.2 Ensembl2168,375,705 - 168,381,528 (+)Ensembl
RefSeq Acc Id: NM_001008724   ⟹   NP_001008724
RefSeq Status: VALIDATED
Rat AssemblyChrPosition (strand)Source
mRatBN7.22168,374,120 - 168,381,523 (+)NCBI
Rnor_6.02181,997,562 - 182,013,521 (+)NCBI
Rnor_5.02201,412,182 - 201,428,346 (+)NCBI
RGSC_v3.42174,737,640 - 174,753,598 (+)RGD
Celera2162,392,064 - 162,408,023 (+)NCBI
RefSeq Acc Id: NM_052797   ⟹   NP_434684
Rat AssemblyChrPosition (strand)Source
mRatBN7.22168,374,138 - 168,380,188 (+)NCBI
Rnor_6.02182,006,336 - 182,012,386 (+)NCBI
Rnor_5.02201,412,182 - 201,428,346 (+)NCBI
RGSC_v3.42174,737,640 - 174,753,598 (+)RGD
Celera2162,400,838 - 162,406,888 (+)NCBI
RefSeq Acc Id: NP_001008724   ⟸   NM_001008724
- Peptide Label: isoform 1 precursor
- UniProtKB: P06399 (UniProtKB/Swiss-Prot),   Q7TQ70 (UniProtKB/TrEMBL),   D3ZJ95 (UniProtKB/TrEMBL),   A0A9K3Y6Z7 (UniProtKB/TrEMBL)
- Sequence:
RefSeq Acc Id: NP_434684   ⟸   NM_052797
- Peptide Label: isoform 2 precursor
- UniProtKB: A1L114 (UniProtKB/TrEMBL)
- Sequence:
RefSeq Acc Id: ENSRNOP00000060007   ⟸   ENSRNOT00000064091
RefSeq Acc Id: ENSRNOP00000088145   ⟸   ENSRNOT00000094522
Protein Structures
Name Modeler Protein Id AA Range Protein Structure
AF-P06399-F1-model_v2 AlphaFold P06399 1-782 view protein structure


eQTL   View at Phenogen
WGCNA   View at Phenogen
Tissue/Strain Expression   View at Phenogen

RGD ID:13691396
Promoter ID:EPDNEW_R1921
Type:multiple initiation site
Description:fibrinogen alpha chain
SO ACC ID:SO:0000170
Source:EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)
Experiment Methods:Single-end sequencing.
Rat AssemblyChrPosition (strand)Source
Rnor_6.02182,006,318 - 182,006,378EPDNEW

Additional Information

Database Acc Id Source(s)
AGR Gene RGD:2603 AgrOrtholog
BioCyc Gene G2FUF-52662 BioCyc
Ensembl Genes ENSRNOG00000024848 Ensembl, ENTREZGENE, UniProtKB/TrEMBL
Ensembl Transcript ENSRNOT00000064091 ENTREZGENE
  ENSRNOT00000064091.4 UniProtKB/TrEMBL
  ENSRNOT00000094522.1 UniProtKB/TrEMBL
Gene3D-CATH UniProtKB/Swiss-Prot, UniProtKB/TrEMBL UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  Gamma-fibrinogen Carboxyl Terminal Fragment, domain 2 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
InterPro Fibrinogen-like_C UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  Fibrinogen_a/b/g_C_1 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  Fibrinogen_a/b/g_C_dom UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  Fibrinogen_a/b/g_coil_dom UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  Fibrinogen_aC UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  Fibrinogen_alpha UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  Fibrinogen_CS UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
KEGG Report rno:361969 UniProtKB/TrEMBL
  PTHR47221 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
Pfam Fib_alpha UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  Fibrinogen_aC UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  Fibrinogen_C UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
PhenoGen Fga PhenoGen
  FIBRINOGEN_C_2 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
RatGTEx ENSRNOG00000024848 RatGTEx
SMART FBG UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  Fib_alpha UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
Superfamily-SCOP Fibrinogen coiled-coil and central regions UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  SSF56496 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
UniProt A0A8I6A5L4_RAT UniProtKB/TrEMBL
  Q4G044_RAT UniProtKB/TrEMBL
UniProt Secondary D3ZJ95 UniProtKB/TrEMBL

Nomenclature History
Date Current Symbol Current Name Previous Symbol Previous Name Description Reference Status
2008-10-17 Fga  fibrinogen alpha chain  Fga  fibrinogen, alpha polypeptide  Nomenclature updated to reflect human and mouse nomenclature 1299863 APPROVED
2002-06-10 Fga  Fibrinogen, A alpha polypeptide      Symbol and Name status set to approved 70586 APPROVED